“pfizer” Archives

in
Entry Author Date Location
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M 09/12/19 San Francisco
As New CEO of Cerevel, Coles Moves From One Neuro Startup to Another 09/09/19 Boston
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint 08/20/19 Indiana
AbbVie’s Successor to Humira Wins FDA OK for Rheumatoid Arthritis 08/16/19 National
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
GlycoMimetics Sickle Cell Drug Flops as Others Creep Forward 08/05/19 New York
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D 07/29/19 New York
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
As Sangamo Touts Data, BioMarin Preps Hemophilia Gene Therapy For FDA 07/08/19 San Francisco
Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More 07/05/19 National
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome 06/26/19 Boulder/Denver
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer 06/19/19 San Diego
Colorectal Cancer Data Spurs Pfizer to Pay $11.4B for Array Bio 06/17/19 Boulder/Denver
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More 06/07/19 National
ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups 05/13/19 Boston
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea 05/06/19 New York
Emtora Biosciences Turns Sights on Rare Genetic Disease, New Funding 04/30/19 Texas
Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer 04/22/19 New York
AskBio Reels In $235M to Advance Gene Therapy Clinical Trials 04/11/19 Raleigh Durham
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
SpringWorks, Armed with Ex-Pfizer Cancer Drugs, Reloads with $125M 04/01/19 New York
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More 03/29/19 National
Page 1 of 30 next page »